NASDAQ Composite ended the session with Catalyst Pharmaceuticals rising 6.33% to $4.87 on Monday while nASDAQ Composite fell 0.48% to $13,895.12.

Catalyst Pharmaceuticals today’s close was $4.87, 6.57% below its 52-week high of $5.19.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 3%, now sitting on 119.07M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $4.87 at 17:22 EST, under its 52-week high of $5.19 and way above its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way higher than its 50-day moving average of $4.11 and way above its 200-day moving average of $3.63.

More news about Catalyst Pharmaceuticals.


Please enter your comment!
Please enter your name here